KLOW Blend dosing schedule
> Updated:
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
KLOW is a combined blend (BPC-157, TB-500, KPV, GHK-Cu; ~80 mg per vial) that protocols administer subcutaneously after reconstitution with bacteriostatic water. The figures below are a generalized reference drawn from public community protocols, not clinical trials.
This is a concise reference to regimens described for adults; it is not an individual prescription.
KLOW blend dosing is counted as total blend milligrams, not per individual peptide across the four components: the table below shows how the total climbs from the starting dose to the intensive regimen.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | ~2 mg total blend per day, subcutaneous | Starting dose |
| Main regimen | 4–6 mg total per day | Increase if needed |
| Intensive | up to 8 mg total per day | Maximum in this schedule |
Practical dosing and effect details
KLOW combines four peptides (BPC-157, TB-500, KPV, GHK-Cu) in one vial, each with its own described protocol when used alone. KPV by itself, for example, most often appears as a once-daily dose of 200 mcg, rising to 500 mcg in the main regimen. In the blend the components are given as a single injection, so the table on this page counts the total blend weight (about 2 mg at the start, 4 to 6 mg in the main regimen) rather than each peptide's individual dose.
That fits the general logic of combined vials: the intensive regimen (up to 8 mg total) likely means more frequent injections of the same mixture rather than doubling a single dose, since one formulation cannot titrate each component on its own. After reconstitution with bacteriostatic water the mixture is kept refrigerated, since prolonged storage at room temperature speeds the loss of activity of the components.
This is reference information for planning a research protocol, not a medical recommendation and not instructions for self-administration.
This reference is research-use material. The information is not medical advice and is not intended for diagnosis, treatment or prevention of disease.